EMA-2023-0002-V402

Type IB variation for application EMA-2023-0002. Type IB variation: Formulation Change for Respiralimab — routine update

Variation Number
EMA-2023-0002-V402
Type
Type IB
Application
EMA-2023-0002
Change
CHG-2023-0102
Status
Submitted
Fee
€1,758
Submitted
2023-10-31
Approved
—
Description

Type IB variation: Formulation Change for Respiralimab — routine update